Bioaster, Cancer Research Center of Lyon, J&J deal

Bioaster, the center and Johnson & Johnson’s Janssen-Cilag S.A.S. company partnered to conduct preclinical R&D of immunotherapeutic treatments for chronic HBV infection. The deal term is two years. ...